A Study to Investigate the Efficacy, Safety, and Tolerability of AZD4144in Participants With Sepsis-associated Acute Kidney Injury.

NCT07215702 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

124

Enrollment

INDUSTRY

Sponsor class

Conditions

Sepsis
Acute Kidney Injury

Interventions

DRUG: AZD4144
DRUG: Placebo

Sponsor

AstraZeneca